Quick Answer
ADIAL PHARMACEUTICALS, INC. reported Total Assets of $6.67 million for the year ending 2025.
- ADIAL PHARMACEUTICALS, INC. showed an increase of +32.3% in Total Assets from 2024 to 2025.
- This data is from ADIAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $187.1 thousand | Q3 2018: $5.25 million | Q1 2019: $12.06 million | Q2 2019: $10.69 million | Q3 2019: $9.51 million | Q1 2020: $5.94 million | Q2 2020: $9.47 million | Q3 2020: $8.18 million | Q1 2021: $8.63 million | Q2 2021: $8.06 million | Q3 2021: $10.45 million | Q1 2022: $13.96 million | Q2 2022: $10.92 million | Q3 2022: $7.74 million | Q1 2023: $3.90 million | Q2 2023: $3.78 million | Q3 2023: $2.87 million | Q1 2024: $6.68 million | Q2 2024: $4.95 million | Q3 2024: $6.71 million | Q1 2025: $3.45 million | Q2 2025: $6.80 million | Q3 2025: $5.66 million.
- Over the full 9 years of available data (2017 to 2025), ADIAL PHARMACEUTICALS, INC.'s Total Assets has grown by 19,217.3%.
- Historical annual values: Fiscal year 2025: $6.67 million | Fiscal year 2024: $5.04 million | Fiscal year 2023: $4.74 million | Fiscal year 2022: $5.73 million | Fiscal year 2021: $7.47 million | Fiscal year 2020: $5.49 million | Fiscal year 2019: $7.68 million | Fiscal year 2018: $4.70 million | Fiscal year 2017: $34.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: